Company / Return on Equity (ROE)
IRONWOOD PHARMACEUTICALS INC Return on Equity (ROE) History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
16.3%
FY2022
5-year range
16.3% / 87.2%
FY2018-FY2022
Trend
-81.3%
vs FY2021
Sector context
#28 of 190
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's return on equity (roe) of 16.3% is higher than 85% of companies in the Health Care sector (FY2022). Improved from -122.5% to 16.3% over the past 4 years.
Based on SEC 10-K filings.
16.3% in FY2022 with a 5-year CAGR of +1203.7%. Top quartile in the Health Care sector.
Improved from -122.5% to 16.3% over the past 4 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +1203.7pp
- 10-Year Change
- -
Sector benchmark
Top 15% in Health CareTop 15% of 190This company 16.3% Sector average -50.4%
▼
+132.3% above sector average
Key checks
Key Insights
- In FY2022, return on equity (roe) decreased 81.3% year-over-year.
- Currently 66.7pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | 16.3% | -81.3% |
| FY2021 | 87.2% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -122.5% | +89.7% |
| FY2017 | -1187.4% | -869.6% |
| FY2016 | -122.5% | +18.3% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026